Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)409
Number of pages1
JournalNeurology
Volume76
Issue number4
DOIs
StatePublished - Jan 25 2011
Externally publishedYes

Fingerprint

Sodium Channel Blockers
Mexiletine
Myotonic Dystrophy
Anti-Arrhythmia Agents

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. / Groh, William.

In: Neurology, Vol. 76, No. 4, 25.01.2011, p. 409.

Research output: Contribution to journalArticle

@article{83326ec9a4d649578f67098055be513f,
title = "Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1",
author = "William Groh",
year = "2011",
month = "1",
day = "25",
doi = "10.1212/WNL.0b013e3181fe72d7",
language = "English",
volume = "76",
pages = "409",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1

AU - Groh, William

PY - 2011/1/25

Y1 - 2011/1/25

UR - http://www.scopus.com/inward/record.url?scp=79251569292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251569292&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e3181fe72d7

DO - 10.1212/WNL.0b013e3181fe72d7

M3 - Article

VL - 76

SP - 409

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 4

ER -